Browsing Tag
DM199
1 post
Diamedica to showcase DM199 at top investor events—can synthetic KLK1 win over Wall Street this time?
Diamedica Therapeutics is set to present at key investor conferences this September. Find out what’s at stake for this clinical-stage biotech firm.